IRIS
BEDOGNETTI, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.035
AS - Asia 152
SA - Sud America 38
NA - Nord America 7
Totale 5.232
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.034
VN - Vietnam 56
SG - Singapore 47
CN - Cina 36
BR - Brasile 27
HK - Hong Kong 6
AR - Argentina 5
ID - Indonesia 5
US - Stati Uniti d'America 5
EC - Ecuador 3
AZ - Azerbaigian 1
BG - Bulgaria 1
CO - Colombia 1
HN - Honduras 1
MX - Messico 1
PK - Pakistan 1
PY - Paraguay 1
UY - Uruguay 1
Totale 5.232
Salva come PNG Salva come JPEG
Città #
Genova 2.852
Genoa 1.540
Vado Ligure 345
Rapallo 290
Ho Chi Minh City 21
Beijing 14
Hanoi 13
Haiphong 6
Hong Kong 6
Singapore 6
Bordighera 5
Biên Hòa 2
Boardman 2
Council Bluffs 2
Da Nang 2
Maceió 2
Phủ Lý 2
Porto Alegre 2
Tianjin 2
Vĩnh Tường 2
Aparecida de Goiânia 1
Arara 1
Ashburn 1
Asunción 1
Baku 1
Bandung 1
Betim 1
Bình Dương 1
Caaporã 1
Carandaí 1
Duque de Caxias 1
Gravataí 1
Guayaquil 1
Jakarta 1
Joinville 1
João Monlevade 1
Lagoa Vermelha 1
Lanús Oeste 1
Llambí Campbell 1
Luján de Cuyo 1
Macarani 1
Malang 1
Matinhos 1
Medan 1
Mexico City 1
Montes Claros 1
Montevideo 1
Nha Trang 1
Ninh Bình 1
Niquelândia 1
Palmópolis 1
Paulínia 1
Presidente Dutra 1
Queimados 1
Quito 1
Recife 1
San Antonio de Padua 1
San Miguel de Tucumán 1
San Pedro Sula 1
Santa Marta 1
Santo André 1
Sofia 1
Sorocaba 1
São Gonçalo 1
Torres 1
Vũng Tàu 1
Totale 5.162
Salva come PNG Salva come JPEG
Nome #
A modular framework for the development of targeted Covid-19 blood transcript profiling panels 308
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 193
Bevacizumab plus fotemustine as first-line treatment in metastatic melanoma patients: clinical activity and modulation of angiogenesis and lymphangiogenesis factors. 187
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. 172
Gene-expression profiling in vaccine therapy and immunotherapy for cancer. 157
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 150
Combination of sorafenib and weekly gemcitabine in patients (pts) with metastatic renal cell Cancer (MRCC): A phase II study, preliminary results 146
Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial 145
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: Meta-analysis of individual patient data from ten randomised trials 144
Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis. 141
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 140
Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer 137
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients. 136
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 135
Inherent transcriptional signatures of NK cells are associated with response to IFNΑ+rivabirin therapy in patients with Hepatitis C Virus 132
Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data. 128
Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer 122
An Open, Randomised, Multicentre, Phase 3 Trial Comparing the Efficacy of Two Tamoxifen Schedules in Preventing Gynaecomastia Induced by Bicalutamide Monotherapy in Prostate Cancer Patients 119
Toward a comprehensive view of cancer immune responsiveness: A synopsis from the SITC workshop 110
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis 95
Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk 93
Monoallelic expression in melanoma 91
Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications 89
Harnessing the immune system for the treatment of melanoma: current status and future prospects 88
Checkpoint Inhibitors and Their Application in Breast Cancer 88
A collection of annotated and harmonized human breast cancer transcriptome datasets, including immunologic classification 88
Conservation of immune gene signatures in solid tumors and prognostic implications 88
Disentangling the relationship between tumor genetic programs and immune responsiveness 86
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications 84
Correction to: Toward a comprehensive view of cancer immune responsiveness: A synopsis from the SITC workshop (Journal for ImmunoTherapy of Cancer (2020) 7 (131) DOI: 10.1186/s40425-019-0602-4) 84
Sterol synthesis pathway inhibition as a target for cancer treatment 83
An integrated tumor, immune and microbiome atlas of colon cancer 82
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines 79
Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod 79
Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: A study protocol 79
Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) 78
Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells 72
Photodynamic therapy based on graphene and MXene in cancer theranostics 72
Interferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype 69
SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer 69
Immunogenic subtypes of breast cancer delineated by gene classifiers of immune responsiveness 65
The Immune Landscape of Cancer 65
The ovarian cancer Chemokine landscape is conducive to homing of vaccine-primed and CD3/CD28-Costimulated T cells prepared for adoptive therapy 65
The immune-related role of BRAF in melanoma 65
Long-Chain Acyl-CoA Synthetase 1 Role in Sepsis and Immunity: Perspectives From a Parallel Review of Public Transcriptome Datasets and of the Literature 65
Molecular and Genomic Impact of Large and Small Lateral Dimension Graphene Oxide Sheets on Human Immune Cells from Healthy Donors 64
Pharmacogenetics driving personalized medicine: Analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations 62
Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients 62
Prognostic and predictive immune gene signatures in breast cancer 60
The MAPK hypothesis: immune-regulatory effects of MAPK-pathway genetic dysregulations and implications for breast cancer immunotherapy 59
Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors 57
Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response 55
Totale 5.382
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.973
article - articoli 19.973
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.946
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021444 0 0 0 0 187 35 5 66 13 96 15 27
2021/2022572 32 22 35 70 14 38 45 125 57 50 21 63
2022/2023385 48 40 13 23 50 53 3 26 44 5 71 9
2023/2024277 7 43 9 47 19 27 6 23 23 7 22 44
2024/20251.110 17 56 22 43 119 143 73 161 25 37 104 310
2025/2026625 164 38 138 121 164 0 0 0 0 0 0 0
Totale 5.382